News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,543 Results
Type
Article (87411)
Company Profile (759)
Press Release (772348)
Multimedia
Podcasts (171)
Webinars (28)
Section
Business (233047)
Career Advice (4139)
Deals (39793)
Drug Delivery (134)
Drug Development (91245)
Employer Resources (203)
FDA (18277)
Job Trends (17399)
News (397371)
Policy (39924)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (232)
Approvals (18293)
Artificial intelligence (484)
Autoimmune disease (69)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (158)
Biotechnology (484)
Bladder cancer (124)
Brain cancer (52)
Breast cancer (481)
Cancer (3846)
Cardiovascular disease (337)
Career advice (3556)
Career pathing (38)
CAR-T (245)
CDC (57)
Cell therapy (678)
Cervical cancer (32)
Clinical research (75355)
Collaboration (1371)
Company closure (4)
Compensation (931)
Complete response letters (59)
COVID-19 (2954)
CRISPR (81)
C-suite (583)
Cystic fibrosis (133)
Data (4325)
Decentralized trials (2)
Denatured (60)
Depression (109)
Diabetes (450)
Diagnostics (7089)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (230)
Drug pricing (188)
Drug shortages (36)
Duchenne muscular dystrophy (202)
Earnings (98776)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132888)
Executive appointments (986)
FDA (20707)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1247)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1016)
Government (5380)
Grass and pollen (7)
Guidances (339)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (56)
Immunology and inflammation (240)
Immuno-oncology (20)
Indications (52)
Infectious disease (3188)
Inflammatory bowel disease (186)
Inflation Reduction Act (15)
Influenza (94)
Intellectual property (186)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (15)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (548)
Lymphoma (263)
Machine learning (29)
Management (66)
Manufacturing (635)
MASH (138)
Medical device (14866)
Medtech (14889)
Mergers & acquisitions (22740)
Metabolic disorders (1146)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2705)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (57)
Obesity (555)
Opinion (311)
Ovarian cancer (127)
Pain (163)
Pancreatic cancer (168)
Parkinson's disease (239)
Partnered (30)
Patents (413)
Patient recruitment (306)
Peanut (57)
People (66242)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23236)
Phase II (32715)
Phase III (24617)
Pipeline (2680)
Policy (295)
Postmarket research (3554)
Preclinical (10490)
Press Release (72)
Prostate cancer (196)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (664)
Real estate (7421)
Recruiting (78)
Regulatory (27969)
Reports (65)
Research institute (2688)
Resumes & cover letters (651)
Rett syndrome (15)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (95)
The Weekly (109)
Vaccines (1039)
Venture capital (66)
Weight loss (393)
Women's health (58)
Worklife (21)
Date
Today (155)
Last 7 days (592)
Last 30 days (2570)
Last 365 days (33563)
2025 (26079)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50934)
Australia (8955)
California (9368)
Canada (2842)
China (883)
Colorado (400)
Connecticut (420)
Delaware (261)
Europe (117054)
Florida (1378)
Georgia (314)
Hawaii (3)
Idaho (67)
Illinois (808)
India (50)
Indiana (458)
Iowa (19)
Japan (314)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1270)
Massachusetts (7059)
Michigan (311)
Minnesota (560)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (77)
New Jersey (2597)
New Mexico (32)
New York (2552)
North Carolina (1408)
North Dakota (10)
Northern California (4217)
Ohio (294)
Oklahoma (22)
Oregon (50)
Pennsylvania (1958)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (48)
South Dakota (1)
Southern California (3585)
Tennessee (149)
Texas (1473)
United States (34696)
Utah (280)
Virginia (247)
Washington D.C. (83)
Washington State (812)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,543 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HARMONi-6 Phase III Study of Ivonescimab Accepted by The Lancet and Selected for ESMO 2025 LBA Presentation
October 16, 2025
·
4 min read
Press Releases
Novartis Fabhalta® (iptacopan) meets Phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy (IgAN)
October 16, 2025
·
11 min read
Press Releases
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
October 16, 2025
·
7 min read
Press Releases
AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors
October 16, 2025
·
4 min read
Press Releases
ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor
October 16, 2025
·
3 min read
Press Releases
Enterome receives FDA Fast Track designation in follicular lymphoma for lead OncoMimics™ immunotherapy EO2463
October 16, 2025
·
4 min read
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 23 October 2025
October 16, 2025
·
1 min read
Press Releases
Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference
October 16, 2025
·
5 min read
Press Releases
C-Path’s Disease Modeling Coalition Begins Global Pediatric IBD Work from European Hub
October 16, 2025
·
3 min read
Press Releases
Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads
October 16, 2025
·
4 min read
1 of 86,055
Next
